Загрузка...
Minimal clinically important difference in idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive fibrosing lung disease with an estimated median survival of 2–5 years and a significant impact on quality of life (QoL). Current approved medications, pirfenidone and nintedanib, have shown a reduction in annual decline of forced vital ca...
Сохранить в:
| Опубликовано в: : | Breathe (Sheff) |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
European Respiratory Society
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8291912/ https://ncbi.nlm.nih.gov/pubmed/34295421 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/20734735.0345-2020 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|